Company intelligence / Profile preview

ExSURE

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

ExSURE is a Singapore-based biotechnology company specializing in exosome-based technologies for cancer diagnostics and therapeutics. Spun off from the National University of Singapore (NUS), the company utilizes its proprietary ExSURE (Exosome-based Surface-modified Ultra-sensitive REporter) platform to detect and analyze exosomal biomarkers with high sensitivity. This platform enables non-invasive liquid biopsies for early cancer detection and monitoring of treatment response. Beyond diagnostics, ExSURE is exploring the use of engineered exosomes as targeted drug delivery vehicles for various oncology indications. The company aims to revolutionize precision medicine by leveraging the unique biological properties of extracellular vesicles.

Therapeutic areas: Oncology
Modalities: Exosome-based therapyLiquid biopsyDiagnostic
Industry: Biotech

Partnerships

National University of SingaporeNational University Health System (NUHS)

Beyond the preview

Go deeper on ExSURE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExSURE.

Explore the full profile